Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSRI Effects on Depression and Immunity in HIV/AIDS
NCT02620150Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by University of Pennsylvania. Started Feb 2017; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02620150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620150.